• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15922 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2011 Andalusian Health Technology Assessment Area (AETSA) [Prioritization of patient decision aids]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Radiofrequency ablation for hepatocellular carcinoma and colorectal liver metastases]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) IFEDH - Innovative Framework for Evidence based Decision making in Health care - principles of standardised work in HTA (WP1.2)
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient cardiac rehabilitation Part 4: Options for carrying out a prospective study]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Quality of care in oncology and its measurement ]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Systematic review of the efficacy and safety of surgery compared to minimally-invasive treatment options for the treatment of varicose veins of the lower extremity]
2011 Haute Autorite de sante (HAS) [A priori evaluation of the expansion of newborn screening to one or more inborn error(s) of metabolism using the technology of tandem mass spectrometry in the general population in France. Part 1: medium chain CoA dehydrogenase deficiency (MCADD)]
2011 Penn Medicine Center for Evidence-based Practice (CEP) Systems for early warning of patient deterioration
2011 Penn Medicine Center for Evidence-based Practice (CEP) Prevention of contrast-induced nephropathy: acetylcysteine, sodium bicarbonate, or saline
2011 Penn Medicine Center for Evidence-based Practice (CEP) Safety and effectiveness of rhBMP-2 (infuse bone graft) for spinal fusion: 2011 update
2011 Penn Medicine Center for Evidence-based Practice (CEP) Telemedicine for patients with congestive heart failure
2011 Penn Medicine Center for Evidence-based Practice (CEP) Healthcare worker clothing and infection control
2011 Penn Medicine Center for Evidence-based Practice (CEP) Thermometers for pediatric use
2011 Penn Medicine Center for Evidence-based Practice (CEP) Thromboelastography for determining transfusion requirements
2011 Penn Medicine Center for Evidence-based Practice (CEP) Telemedicine in follow-up of chemotherapy patients
2011 Penn Medicine Center for Evidence-based Practice (CEP) Brief screening tests for depression in emergency patients
2011 Penn Medicine Center for Evidence-based Practice (CEP) Antibiotic management for pediatric appendicitis
2011 Penn Medicine Center for Evidence-based Practice (CEP) Seasonal variation in readmission rates
2011 Penn Medicine Center for Evidence-based Practice (CEP) Collection and testing of urine samples for suspected urinary tract infection in children
2011 Penn Medicine Center for Evidence-based Practice (CEP) One to one nursing care for patient safety
2011 Penn Medicine Center for Evidence-based Practice (CEP) GI bleeding prophylaxis for critical care patients
2011 Institut national d'excellence en sante et en services sociaux (INESSS) [Treatment of esophageal cancer: systematic review on surgical techniques]
2011 Institut national d'excellence en sante et en services sociaux (INESSS) [Surgical treatment of esophageal cancer: effect of operative volume on clinical outcomes]
2011 NIHR Horizon Scanning Centre (NIHR HSC) Soundbite hearing system
2011 NIHR Horizon Scanning Centre (NIHR HSC) Abraxane for non-small cell lung cancer, advanced and/or metastatic - first line, in combination with carboplatin
2011 NIHR Horizon Scanning Centre (NIHR HSC) Desmoteplase for acute ischaemic stroke
2011 NIHR Horizon Scanning Centre (NIHR HSC) Otamixaban for non-ST elevation acute coronary syndrome (NSTE ACS) - patients undergoing planned invasive treatment
2011 NIHR Horizon Scanning Centre (NIHR HSC) Prasugrel (Efient) for the prevention of atherothrombotic events in patients with acute coronary syndromes who will be managed without acute coronary revascularisation - in combination with aspirin
2011 NIHR Horizon Scanning Centre (NIHR HSC) Lu AA21004 for major depressive disorder
2011 NIHR Horizon Scanning Centre (NIHR HSC) Ocriplasmin (Microplasmin) for symptomatic vitreomacular adhesion (sVMA) - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Certolizumab pegol (Cimzia) for psoriatic arthritis - second line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Infrared lasers for treating onychomycosis
2011 NIHR Horizon Scanning Centre (NIHR HSC) Golimumab (Simponi) for ulcerative colitis - second line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Infliximab (Remicade) for paediatric ulcerative colitis
2011 NIHR Horizon Scanning Centre (NIHR HSC) Amniotic Fluid Lactate monitoring system for dysfunctional labour
2011 NIHR Horizon Scanning Centre (NIHR HSC) Placental growth factor based tests for the diagnosis of pre-eclampsia
2011 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) for advanced gastric cancer - second line
2011 NIHR Horizon Scanning Centre (NIHR HSC) GSK1120212 for unresectable or metastatic melanoma, BRAF V600 mutation-positive in adults
2011 NIHR Horizon Scanning Centre (NIHR HSC) GSK2118436 (dabrafenib) for malignant melanoma: advanced and/or metastatic (stage III or IV), BRAF V600E mutation - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Regorafenib for metastatic colorectal cancer - third or fourth line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for hepatocellular carcinoma - adjuvant therapy
2011 NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) in combination with capecitabine for HER2-negative locally advanced or metastatic breast cancer - second line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Exenatide (Byetta) for type 2 diabetes mellitus - in combination with basal insulin
2011 NIHR Horizon Scanning Centre (NIHR HSC) Aganirsen for pathological corneal neovascularisation
2011 NIHR Horizon Scanning Centre (NIHR HSC) Idebenone (Catena) for leber's hereditary optic neuropathy - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for visual impairment due to choroidal neovascularisation (CNV) secondary to pathological myopia - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Defibrotide (Defitelio) for hepatic veno-occlusive disease in haematopoietic stem cell transplantation - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Certolizumab pegol (Cimzia) for active ankylosing spondylitis (AS) - second or third line; after intolerance or inadequate response to at least one non-steroidal anti-inflammatory drug (NSAID)
2011 NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (Prolia) for osteoporosis in men
2011 NIHR Horizon Scanning Centre (NIHR HSC) Laquinimod for multiple sclerosis: relapsing-remitting - first or second line.
2011 NIHR Horizon Scanning Centre (NIHR HSC) Teriflunomide for relapsing multiple sclerosis (MS) - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Eculizumab (Soliris) for atypical haemolytic uraemic syndrome - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Indacaterol/glycopyrronium (QVA-149) for chronic obstructive pulmonary disease
2011 Institut national d'excellence en sante et en services sociaux (INESSS) [Treatment of cancer-related secondary lymphedema]
2011 Institut national d'excellence en sante et en services sociaux (INESSS) [Organization of stroke care services]
2011 Institut national d'excellence en sante et en services sociaux (INESSS) [Home diagnosis of obstructive sleep apnea in children]
2011 Institut national d'excellence en sante et en services sociaux (INESSS) [Rare disease management: experiences from abroad]
2011 Medical Services Advisory Committee (MSAC) Review of interim funded service: Artificial intervertebral disc replacement - lumbar
2011 Health Council of the Netherlands Gezondheidsraad (GR) Q fever: risk of transmission via blood or other body material
2011 Health Council of the Netherlands Gezondheidsraad (GR) Antibiotics in food animal production and resistant bacteria in humans
2011 Health Council of the Netherlands Gezondheidsraad (GR) Malnutrition in the elderly
2011 The Regional Health Technology Assessment Centre (HTA-centrum) Bone anchored hearing aid in patients with unilateral hearing loss
2011 The Regional Health Technology Assessment Centre (HTA-centrum) [Surgical stabilization of a flail chest wall]
2011 The Regional Health Technology Assessment Centre (HTA-centrum) [Active mobilization after flexor tendon repairs in zone II of the hand]
2011 The Regional Health Technology Assessment Centre (HTA-centrum) Corneal crosslinking in keratoconus
2011 The Regional Health Technology Assessment Centre (HTA-centrum) [Laparoscopic surgery in kidney neoplasms]
2011 The Regional Health Technology Assessment Centre (HTA-centrum) [Robotic surgery for benign gynecologic disease]
2011 The Regional Health Technology Assessment Centre (HTA-centrum) [Benefit of phrenic nerve stimulation for patients with complete traumatic lesion of the spinal cord and loss of spontaneous breathing]
2011 The Regional Health Technology Assessment Centre (HTA-centrum) [Effects on adherence to clinical guidelines by active 'on screen' computer-based clinical decision support systems]
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) [Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2011 Andalusian Health Technology Assessment Area (AETSA) [Biological therapies in the treatment of rheumatoid arthritis]
2011 NIHR Horizon Scanning Centre (NIHR HSC) Abraxane for malignant melanoma – first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for triple negative adjuvant breast cancer; in combination with taxane and/or anthracycline chemotherapy
2011 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) with octreotide (Sandostatin) for high risk carcinoid tumours – first or second line
2011 Andalusian Health Technology Assessment Area (AETSA) [Use of QALYs in different clinical situations]
2011 Andalusian Health Technology Assessment Area (AETSA) [Impella Recover® 2.5 ventricular assist device]
2011 Andalusian Health Technology Assessment Area (AETSA) [Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2011 Health Information and Quality Authority (HIQA) A health technology assessment of prion filtration of red cell concentrates to reduce the risk of variant Creutzfeldt-Jakob disease transmission in Ireland
2011 NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) in combination with oxaliplatin, leucovorin and fluorouracil for colorectal cancer - adjuvant
2011 NIHR Horizon Scanning Centre (NIHR HSC) Brivanib for hepatocellular carcinoma – second line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) in combination with capecitabine and cisplatin for advanced or metastatic gastric cancer – first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Dasatinib (Sprycel) for prostate cancer – in combination with docetaxel
2011 NIHR Horizon Scanning Centre (NIHR HSC) EC145 for folate receptor positive ovarian cancer
2011 NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with sorafenib (Nexavar) for unresectable, advanced or metastatic hepatocellular carcinoma – first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Heat-activated liposome encapsulated doxorubicin (ThermoDox) for hepatocellular carcinoma – first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for prostate cancer – second line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Masitinib with gemcitabine for advanced or metastatic pancreatic cancer
2011 NIHR Horizon Scanning Centre (NIHR HSC) Paclitaxel (Paclical) for epithelial ovarian cancer, fallopian tube cancer or peritoneal cancer – second or third line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Dalcetrapib for the prevention of cardiovascular events
2011 NIHR Horizon Scanning Centre (NIHR HSC) Edoxaban tosylate for prevention of stroke and systemic embolic events in non-valvular atrial fibrillation
2011 NIHR Horizon Scanning Centre (NIHR HSC) HHLivC (Human Heterologous Liver Cells) for urea cycle disorders
2011 NIHR Horizon Scanning Centre (NIHR HSC) ThromboLUX™ for determining platelet quality
2011 NIHR Horizon Scanning Centre (NIHR HSC) Rituximab (MabThera) for anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis
2011 NIHR Horizon Scanning Centre (NIHR HSC) Odanacatib for post-menopausal osteoporosis – first or second line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Tocilizumab (RoACTEMRA) for early rheumatoid arthritis not treated with methotrexate – first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Dimethyl fumarate for relapsing-remitting multiple sclerosis
2011 NIHR Horizon Scanning Centre (NIHR HSC) Lacosamide (Vimpat) for epilepsy – first and second line
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Guidelines and recommendations for ADHD in children and adolescents
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pre-operative testing and assessment for adult patients undergoing elective surgical procedures: a review of the clinical evidence and guidelines